Sort
30,917 grants matching “tumor microenvironment”
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$370,575Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$370,575Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
$370,575Weibo Luo · Ut Southwestern Medical Center · R01 · FY2022 · CA
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
$370,575Jinming Gao · Ut Southwestern Medical Center · R01 · FY2018 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2016 · CA
Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs
$370,575Angelique Wright Whitehurst · Ut Southwestern Medical Center · R01 · FY2017 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2017 · CA
Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer
$370,575William H Matsui · Johns Hopkins University · R01 · FY2016 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2018 · CA
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
$370,575Weibo Luo · Ut Southwestern Medical Center · R01 · FY2021 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$370,575Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Dissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Dissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Novel Targeted Therapeutics for Breast Cancer
$370,575Bulent Ozpolat · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
$370,575Juan Fueyo · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Novel Targeted Therapeutics for Breast Cancer
$370,575Bulent Ozpolat · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2020 · CA
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
$370,575Timothy Anthony Yap · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$370,575Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2021 · CA
Novel Mechanisms of Cancer Bone Metastasis
$370,575Yihong Wan · Ut Southwestern Medical Center · R01 · FY2020 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2020 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer
$370,575William H Matsui · Johns Hopkins University · R01 · FY2017 · CA
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
$370,575Jinming Gao · Ut Southwestern Medical Center · R01 · FY2017 · CA